Skip to content
Log in
Sponsored AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI
Review Open access

Managing Cardiogenic Shock in the Era of Multimodal Mechanical Support: Bridging to Transplant or Recovery

Jorge A Ortega-Hernández L. Baldetti G. Gallone G. Cacioli P. Bocchino Gabriela Rojas-Cruz R. Neri-Bale Antonio Loforte J. Hernández-Montfort
Aug 2026 · Current Heart Failure Reports · Vol 23 · 0 citations · 92 references
Medicine

TL;DR

Current evidence on device-specific physiology, escalation and weaning, pulmonary vascular considerations, and post-transplant outcomes are summarized, and an integrated framework for individualized, trajectory-based decision-making is proposed.

DOI PubMed Semantic Scholar
Read PDF

Similar papers

Review Sep 2026

Next Generation Temporary Mechanical Circulatory Support for Cardiogenic Shock.

Cardiogenic shock remains the leading cause of death in patients with acute myocardial infarction and severe acute heart failure. Temporary mechanical circulatory support devices have emerged as important adjuncts for restoring systemic perfusion, unloading the failing ventricle, and stabilizing patients for cardiogeni...

Holger Thiele, S. von der Emde, A. Freund · 0 citations
Review Open access Sep 2026

Temporary Mechanical Circulatory Support in Patients in Cardiogenic Shock Requiring Cardiac Surgery: Protected Cardiac Surgery Concept

This review describes three clinical scenarios: preoperative stabilization and bridge-to-surgery, planned intraoperative support in patients at high risk of perioperative low cardiac output, and rescue support for failure to wean from cardiopulmonary bypass or postoperative heart failure.

Anika Nagel, Dominik Geiger, G. Nersesian et al. · 0 citations
Review Sep 2026

Cardiogenic Shock Management: A Framework for Individualized Microaxial Flow Pump Support.

Cardiogenic shock (CS) is a highly heterogeneous syndrome with persistently high mortality despite advances in therapies, including temporary mechanical circulatory support. The disparate results of trials on temporary mechanical circulatory support in CS suggest that improved strategies, including better patient selec...

C. Starling, Jonathan D. Moreno, Walter Schiffer et al. · 0 citations
Case report Aug 2026

276 Days of Support by a Micro-Axial Left Ventricular Assist Device as a Bridge to Heart Transplant.

The Impella 5.5 is a surgically implanted micro-axial left ventricular assist device (LVAD) increasingly utilized for mechanical circulatory support (MCS) in cardiogenic shock. While typically used for acute support up to FDA-approved 14 days, reports of prolonged utilization remain limited. We present the case of a 69...

J. Shimamura, A. Levine, Stephen Pan et al. · 1 citation
Review Sep 2026

Management of shock phenotypes after cardiac arrest: beyond cardiogenic shock.

PURPOSE OF REVIEW Postcardiac-arrest circulatory failure is commonly labeled cardiogenic shock, although its physiology is heterogeneous, dynamic, and frequently mixed. This review examines recent evidence and proposes a treatment-oriented framework. RECENT FINDINGS Hypotension, hyperlactatemia, vasopressor dependenc...

J. Grand, S. Schneekloth, R. Beske · 0 citations
Review Open access Sep 2026

From innovation to implementation: expanding global access to mechanical circulatory support and heart transplantation

Mechanical circulatory support (MCS) and heart transplantation are established therapies for advanced heart failure and cardiogenic shock. Technological advances have improved outcomes, including randomized evidence supporting the use of temporary MCS, such as percutaneous ventricular assist devices, in selected patien...

Laith Alhuneafat, Omar Obeidat, Kevin G. Buda et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.